Bone Marrow Mesenchymal Stem Cells-Derived Extracellular Vesicles Promote Proliferation, Invasion and Migration of Osteosarcoma Cells via the lncRNA MALAT1/miR-143/NRSN2/Wnt/β-Catenin Axis

References

• Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg. 2016;82(4):690–698.
   PubMed Web of Science ®Google Scholar
• Simpson E, Brown HL. Understanding osteosarcomas. JAAPA. 2018;31(8):15–19. doi:10.1097/01.JAA.0000541477.24116.8d
   PubMedGoogle Scholar
• Yan L, Wu X, Liu Y, Xian W. LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765. J Cell Biochem. 2018.
   Web of Science ®Google Scholar
• Kager L, Tamamyan G, Bielack S. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 2017;13(4):357–368. doi:10.2217/fon-2016-0261
   PubMed Web of Science ®Google Scholar
• Mori K, Redini F, Gouin F, Cherrier B, Heymann D. Osteosarcoma: current status of immunotherapy and future trends (review). Oncol Rep. 2006;15(3):693–700.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wang G, Chen R, Hua Y, Cai Z. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications. Stem Cell Res Ther. 2018;9(1):22. doi:10.1186/s13287-018-0780-x
   PubMedGoogle Scholar
• Qin F, Tang H, Zhang Y, Zhang Z, Huang P, Zhu J. Bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-208a promotes osteosarcoma cell proliferation, migration, and invasion. J Cell Physiol. 2020;235(5):4734–4745. doi:10.1002/jcp.29351
   PubMed Web of Science ®Google Scholar
• Sun Y, Huo C, Qiao Z, et al. Comparative proteomic analysis of exosomes and microvesicles in human saliva for lung cancer. J Proteome Res. 2018;17(3):1101–1107. doi:10.1021/acs.jproteome.7b00770
   PubMed Web of Science ®Google Scholar
• Baglio SR, Lagerweij T, Perez-Lanzon M, et al. Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression. Clin Cancer Res. 2017;23(14):3721–3733. doi:10.1158/1078-0432.CCR-16-2726
   PubMed Web of Science ®Google Scholar
• Qi J, Zhou Y, Jiao Z, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through hedgehog signaling pathway. Cell Physiol Biochem. 2017;42(6):2242–2254. doi:10.1159/000479998
   PubMedGoogle Scholar
• Yang J, Li C, Zhang L, Wang X. Extracellular vesicles as carriers of non-coding RNAs in liver diseases. Front Pharmacol. 2018;9:415. doi:10.3389/fphar.2018.00415
   PubMed Web of Science ®Google Scholar
• Cheng J, Chen J, Zhang X, Mei H, Wang F, Cai Z. Overexpression of CRNDE promotes the progression of bladder cancer. Biomed Pharmacother. 2018;99:638–644. doi:10.1016/j.biopha.2017.12.055
   PubMed Web of Science ®Google Scholar
• Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA malat1: its physiological and pathophysiological functions. RNA Biol. 2017;14(12):1705–1714. doi:10.1080/15476286.2017.1358347
   PubMed Web of Science ®Google Scholar
• Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer. RNA Biol. 2019;16(6):860–863. doi:10.1080/15476286.2019.1592072
   PubMed Web of Science ®Google Scholar
• Yang X, Yang J, Lei P, Wen T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging (Albany NY). 2019;11(20):8777–8791. doi:10.18632/aging.102264
   PubMedGoogle Scholar
• Wang Y, Chu Y, Li K, et al. Exosomes secreted by adipose-derived mesenchymal stem cells foster metastasis and osteosarcoma proliferation by increasing COLGALT2 expression. Front Cell Dev Biol. 2020;8:353. doi:10.3389/fcell.2020.00353
   PubMed Web of Science ®Google Scholar
• Yu FX, Hu WJ, He B, Zheng YH, Zhang QY, Chen L. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion. World J Surg Oncol. 2015;13(1):52. doi:10.1186/s12957-015-0465-1
   PubMedGoogle Scholar
• Smolle MA, Pichler M. The role of long non-coding RNAs in osteosarcoma. Noncoding RNA. 2018;4(1):1. doi:10.3390/ncrna4010007
   Google Scholar
• Duan G, Zhang C, Xu C, Xu C, Zhang L, Zhang Y. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR34a/cyclin D1 axis. Int J Oncol. 2019;54(1):17–28. doi:10.3892/ijo.2018.4600
   PubMed Web of Science ®Google Scholar
• Keremu A, Maimaiti X, Aimaiti A, et al. NRSN2 promotes osteosarcoma cell proliferation and growth through PI3K/Akt/MTOR and Wnt/beta-catenin signaling. Am J Cancer Res. 2017;7(3):565–573.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu S, Chen Y, et al. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma. Exp Biol Med (Maywood). 2015;240(7):867–875. doi:10.1177/1535370214563893
   PubMed Web of Science ®Google Scholar
• Wu BQ, Cao Y, Bi ZG. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/beta-catenin signal pathway. Eur Rev Med Pharmacol Sci. 2017;21(14):3185–3192.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Nogales C, Moreno H, Zandueta C, et al. Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma. Cancers (Basel). 2020;12(7):1895. doi:10.3390/cancers12071895
   PubMed Web of Science ®Google Scholar
• Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78. doi:10.1016/j.pharmthera.2017.02.020
   PubMed Web of Science ®Google Scholar
• Kosaka N, Yoshioka Y, Fujita Y, Ochiya T. Versatile roles of extracellular vesicles in cancer. J Clin Invest. 2016;126(4):1163–1172. doi:10.1172/JCI81130
   PubMed Web of Science ®Google Scholar
• Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638.
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:3. doi:10.3402/jev.v3.24641
   Google Scholar
• Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836–848. doi:10.1016/j.ccell.2016.10.009
   PubMed Web of Science ®Google Scholar
• Perut F, Roncuzzi L, Baldini N. The emerging roles of extracellular vesicles in osteosarcoma. Front Oncol. 2019;9:1342. doi:10.3389/fonc.2019.01342
   PubMed Web of Science ®Google Scholar
• Kong G, Qi XJ, Wang JF. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells. Eur Rev Med Pharmacol Sci. 2018;22(6):1609–1614. doi:10.26355/eurrev_201803_14567
   PubMed Web of Science ®Google Scholar
• Zheng S, Jiang F, Ge D, et al. LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother. 2019;112:108695. doi:10.1016/j.biopha.2019.108695
   PubMed Web of Science ®Google Scholar
• Zhou S, Yu L, Xiong M, Dai G. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res Commun. 2018;495(2):1822–1832. doi:10.1016/j.bbrc.2017.12.047
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang W, Sun W, et al. LncRNA MALAT1 promotes cancer metastasis in osteosarcoma via activation of the PI3K-Akt signaling pathway. Cell Physiol Biochem. 2018;51(3):1313–1326. doi:10.1159/000495550
   PubMedGoogle Scholar
• Jiao D, Li Z, Zhu M, Wang Y, Wu G, Han X. LncRNA MALAT1 promotes tumor growth and metastasis by targeting miR-124/foxq1 in bladder transitional cell carcinoma (BTCC). Am J Cancer Res. 2018;8(4):748–760.
   PubMedGoogle Scholar
• Wang J, Liu S, Shi J. The role of miRNA in the diagnosis, prognosis, and treatment of osteosarcoma. Cancer Biother Radiopharm. 2019;34(10):605–613. doi:10.1089/cbr.2019.2939
   PubMed Web of Science ®Google Scholar
• Dong X, Lv B, Li Y, Cheng Q, Su C, Yin G. MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7. Arch Biochem Biophys. 2017;630:47–53. doi:10.1016/j.abb.2017.07.011
   PubMed Web of Science ®Google Scholar
• Tang W, Ren A, Xiao H, Sun H, Li B. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer. Biomed Pharmacother. 2017;85:248–255. doi:10.1016/j.biopha.2016.11.012
   PubMed Web of Science ®Google Scholar
• Ren F, Zhang W, Lu S, Ren H, Guo Y. NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-kappaB signaling pathways. Oncol Lett. 2020;19(1):813–823. doi:10.3892/ol.2019.11152
   PubMed Web of Science ®Google Scholar
• Hou Y, Feng H, Jiao J, et al. Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7. Artif Cells Nanomed Biotechnol. 2019;47(1):2065–2071. doi:10.1080/21691401.2019.1620252
   PubMed Web of Science ®Google Scholar
• Shimbo K, Miyaki S, Ishitobi H, et al. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun. 2014;445(2):381–387. doi:10.1016/j.bbrc.2014.02.007
   PubMed Web of Science ®Google Scholar
• Fang F, VanCleave A, Helmuth R, et al. Targeting the Wnt/beta-catenin pathway in human osteosarcoma cells. Oncotarget. 2018;9(95):36780–36792. doi:10.18632/oncotarget.26377
   PubMedGoogle Scholar